Replies to post #3578 on Enanta Pharmaceuticals Inc (ENTA)

[DewDiligence]

ENTA’s fully-diluted share count @12/31/24=27.95M—an increase of 0.96M since 9/30/24 due to the end-of-fiscal-year options granted on 11/27/24.

The 27.95M figure consists of: 21.33M basic shares on the 12/31/24 balance sheet (https://www.sec.gov/ix?doc=/Archives/edgar/data/0001177648/000095017025018810/enta-20241231.htm p.3); and 6.62M options and unvested restricted-stock shares and equivalents (whether or not exercisable) (ibid, p.9).

NOTE: My method of counting fully-diluted shares is intentionally a maximum-case scenario—i.e. intentionally conservative for calculating enterprise value. My count includes all options, regardless of how far out of the money they may be.